Hemostasis in liver diseases;Hamostasedefekt im rahmen von leberfunktionsstorungen

Intensivmedizin und Notfallmedizin

Volumn 35, Issue SUPPL. 1, 1998, Pages 109-117

  Riess, H ^a   Bechstein, W O ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Aprotinin; Hyperfibrinolysis; Inflammatory response; Leucocytic activation; Liver diseases; Liver transplantation

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ANTITHROMBIN III; APROTININ; BLOOD CLOTTING FACTOR 13; FIBRINOGEN; HEPARIN; PROTHROMBIN COMPLEX; TRANEXAMIC ACID; VITAMIN K GROUP;

ADULT; BLOOD CLOTTING; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRINOLYSIS; GRAFT VERSUS HOST REACTION; HEMOSTASIS; HUMAN; LIVER DISEASE; LIVER FUNCTION; LIVER PARENCHYMA; LIVER TRANSPLANTATION; MALE; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PROTEIN SYNTHESIS; RETICULOENDOTHELIAL SYSTEM; REVIEW; THROMBOEMBOLISM;

EID: 0031714507     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Bakker CM, Metselaar HJ, Groenland THN et al. (1992) Increased tissue-type plasminogen activator activity in orthotopic but not in heterotopic liver transplantation. The role of anhepatic period, Hepatology 16: 40-48
2. Baudo F, De Gasperi A, Belli L et al. (1991) Antithormbin III, blood loss, and transfusion requirements during liver transplantation. Lancet 338: 897
3. Bechstein WO, Riess H, Neuhaus P, Himmelreich G, Steffen R, Slama KJ, Rossant R, Blumhardt G (1991) The effect of aprotinin on blood product requirements during orthotopic liver transplantation. Clin Transplantation 5: 422-426
4. Böhming HJ (1977) The coagulation disorder of orthotopic hepatic transplantation. Semin Thromb Hemostasis 4: 57-82
5. Boylan JF, Klinck JR, Sandler AN, Arellano R, Greig PD, Nierenberg H, Roger SL, Glynn MF (1996) Tranexamic acid reduces blod loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 85 (5): 1043-1048
6. Dzik WH, Arkin CF, Jenkins RL, Stump DC (1988) Fibrinolysis during liver transplantation in humans. Role of tissue-type plasminogen activator. Blood 71: 1090-1095
7. Flute PJ, Rake MO, Williams R et al. (1969) Liver transplantation in man IV. Haemorrhage and thrombosis. Br Med J 3: 20-23
8. Grosse H, Lobbes W, Frambach M et al. (1991) The use of high dose aprotinin in liver transplantation. The influence of fibrinolysis and blood loss. Thromb Res 63: 287-297
9. Grossi CE, Rousselot LM, Panke WF (1962) Coagulation defects in patients with cirrhosis of the liver undergoing portasystemic shunts. Am J Surg 104: 512-525
10. Groth CG, Pechet L, Starzl TE (1969) Coagulation during and after orthotopic transplantation of the human liver. Arch Surg 98. 31-34
11. Harper PL, Luddington RJ, Jennings L, Reardon D, Seaman MJ, Carrell RW, Klinik JR, Smith M, Rolles K, Calne R (1989) Coagulation changes following hepatic revascularisation during liver transplantation. Transplantation 48: 603-607
12. Hashikura Y, Kawasaki S, Okumura N et al. (1995) Prevention of hepatic artery thrombosis in pediatric liver transplantation. Transplantation 60 (10): 1109-1112
13. Himmelreich G, Dooijewaard G, Breindl P, Bechstein WO, Neuhaus P, Kluft C, Riess H (1993) Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (T-PA) in orthotopic liver transplantation (OLT). Thromb Haemostas 69: 56-58
14. Himmelreich G, Dooijewaard G, Neuhaus P, Kluft C, Bechstein WO, Riess H (1994) Increased urokinase-type plasminogen activator (u-PA) levels in graft liver perfusate and decreased single chain u-PA activation with higher levels of aprotinin. Thromb-Haemost 71: 12-14
15. Himmelreich G, Hundt K, Neuhaus P, Bechstein WO, Roissant R, Riess H (1993) Evidence that intraoperative prostaglandine E1 infusion reduces impaired platelet aggregation after reperfusion in orthotopic liver transplantation. Transplantation 55: 819-826
16. Himmelreich G, Kierzek B, Neuhaus P, Slama K-J, Riess H (1991) Coagulation changes and the influence of the early perfusate in the course of orthotopic liver transplantation (OLT) when aprotinin is used intraoperatively. Blood Coagulation and Fibrinolysis 2: 51-59
17. Himmelreich G, Riess H (1991) In vitro inhibition of platelet aggregation by the liver preservation fluid UW solution. Transplantation 52: 30-33
18. Himmelreich G, Riewald M, Blumhard G, Neuhaus P, Roissaint R, Riess H (1994) Thrombomodulin: a marker for endothelial damage during orthotopic liver transplantation. Am J Hematol 47: 1-5
19. Himmelreich G, Hundt K, Neuhaus P, Blumhardt G, Riess H (1992) Decreased platelet aggregation after reperfusion in orthotopic liver transplantation. Transplantation 53: 582-586
20. Himmelreich G, Jochum M, Bechstein WO, Machleidt W, Neuhaus P, Slama KJ, Riess H (1994) Mediators of leukocyte activation play a role in disseminated intravascular coagulation during orthotopic liver transplantation. Transplantation 57 (3): 354-358
21. Himmelreich G, Muser M, Neuhaus P, Bechstein WO, Salama K-J, Jochum M, Riess H (1992) Different aprotinin applications influencing hemostatic changes in orthotopic liver transplantation. Transplantation 55: 132-136
22. Kang YG, Lewis JH, Navalgund A, Russell MW, Bontempo FA, Niren LS, Starzl TE (1987) Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology 66: 766-773
23. Legare G, Roy A, Dagenais M, Lapointe R, Marleau D, Thout C (1996) Reduction of blood loss in orthotopic liver transplantation with the use of aprotinin. Ann Chir 50 (8): 601-605
24. Marcel RJ, Stegall WC, Suit CT et al. (1996) Continuous small-dose aprotinin controls fibrinolysis during orthotopic liver transplantation. Anest Analg 82 (6): 1122-1125
25. Moriau M, Kestens PJ, Masure R (1969) Heparin and antifibrinolytic agents during experimental hepatectomy and liver transplantation. Pathol Eur 4: 172-182
26. Neuhaus P, Bechstein WO, Lefèbre B, Blumhardt G, Slama K (1988) Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation. Lancet 2: 1924-14
27. Oksuzoglu G, Simsek H, Haznedaroglu IC, Kirazli S (1997) Tissue factor pathway inhibitor concentrations in cirrhotic patients with and without portal vein thrombosis. Am J Gastroenterol 92 (2): 303-306
28. Palareti G, Legagni C, Maccaferri M et al. (1991) Coagulation and fibrinolysis in liver transplantation. The role of the recipient's disease and the use of antithrombin-III concentrates. Haemostasis 21: 68-76
29. Porte RJ, Bontempo FA, Knot EAR et al. (1989) Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin formation in orthotopic liver transplantation. Transplantation 47: 978-985
30. Porte RJ, Knot EAR, Bontempo FA (1989) Hemostasis in liver transplantation: a review. Gastroenterology 97: 488-501
31. Pramoolsinsap C, Busargom N, Kurathong S (1996) Haemostatic abnormalities in patients with liver disease associated with viral hepatitis. J Med Assoc Thai 79 (11): 681-688
32. Riess H, Jochum M, Machleidt W, Himmelreich G, Roissaint R, Steffen R (1991) Possible role of extracellularly released phagocyte proteinases in the coagulation disorder during liver transplantation. Transplantation 52: 482-490
33. Riess H (1995) The use of aprotinin in liver transplantation. In: Pifarré R: Blood conservation with aprotinin. Hanley & Belfus, Inc. Philadelphia 349-358
34. Riess H (1996) Role of mediators released by leukocytes during liver transplantation as possible contributing factor for hyperfibrinolysis and DIC. In:Glas-Greenswalt P.: Fibrinolysis in Disease. Molecular and hemovascular aspects of fibrinolysis. CRC Press, Boca Raton, New York, London, Tokyo, 211-215
35. Sato M, Bashan B, Ringe B et al. (1991) Coagulation disorder during liver transplantation. Blood Coag Fibrinol 2: 25-31
36. Segal HC, Hunt BJ, Cottam S et al. (1995) Changes in the contact system during orthotopic liver transplantation with and without aprotinin. Transplantation 59 (3): 366-370
37. Soilleuy H, Gillon MC, Mirand A et al. (1995) Comparative effects of small and large aprotinin doses on bleeding during orthotopic liver transplantation. Anesth Analg 80: 349-352
38. Starzl TE, Iwatsuki S, Van Thiel DH et al. (1982) Evolution of liver transplantation. Hepatology 2: 674-636
39. Starzl TE, Marchioro KN, Von Kaulla et al. (1963) Homotransplantation of the liver in humans. Surg Gynecol Obstet 117: 659-676
40. Wüthrich B, Schmid P, Schmid ER et al. (1992) IgE-mediated anaphylactic reaction to aprotinin during anaesthesia. Lancet 340: 173-174